Skip to main content
SpringerLink
Log in

Multimodality therapy for gastroesophageal cancers

  • Published:
Journal of Gastrointestinal Surgery

Summary

Multimodality therapy is the key to the treatment of carcinomas of the gastroesophageal junction. Chemoradiation followed by esophagectomy appears to be the standard therapy at the present time. Selected patients who respond completely to the chemotherapy and radiation are probably the best candidates for esophagectomy. Although extended lymph node dissection is advocated, there are not sufficient data to determine whether the increased morbidity of the procedure is justified by the improvement in outcome for junctional cancers. Early cancers in nonsurgical patients could potentially be treated by endoscopic methods including endoscopic mucosal resection, which permits accurate staging, and photodynamic therapy, which permits treatment of residual premalignant tissue. Palliation of patients with advanced cancers of the gastroesophageal junction is probably best managed with expandable metal stents, although there is some evidence to suggest that thermal methods of palliation may enhance the quality of life in these patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Stein,HJ,Feith,M,Siewert,JR. Cancer of the esophagogastric junction. Surg Oncol 2000;9:35–41.

    Article  PubMed  CAS  Google Scholar 

  2. Falk,GW. Gastroesophageal reflux disease and Barrett’s esophagus. Endoscopy 2001;33:109–1 18.

    Article  PubMed  CAS  Google Scholar 

  3. El-Zimaity,HM,Ramchatesingh,J,Saeed,MA,Graham,DY. Gastric intestinal metaplasia: Subtypes and natural history. J Clin Pathol 2001;54:679–683.

    PubMed  CAS  Google Scholar 

  4. Mark,SD,Qiao,YL,Dawsey,SM,Wu,YP,Katki,H,Gunter,EW,Fraumeni,JF Jr,Blot,WJ,Dong,ZW,Taylor,PR. Prospective study of serum selenium levels and incident esophageal and gastric cancers. J Natl Cancer Inst 2000;92:1753–1763.

    Article  PubMed  CAS  Google Scholar 

  5. Luketich,JD,Schauer,P,Urso,K,Kassis,E,Ferson,P,Keenan,R, Landreneau,R. Future directions in esophageal cancer. Chest 1998;113(Suppl 1):120S-122S.

    PubMed  CAS  Google Scholar 

  6. Meltzer,CC,Luketich,JD,Friedman,D,Charron,M,Strollo,D,Meehan,M, Urso,GK,Dachille,MA,Townsend,DW. Whole-body FDG positron emission tomographic imaging for staging esophageal cancer comparison with computed tomography. Clin Nucl Med 2000;25:882–887.

    Article  PubMed  CAS  Google Scholar 

  7. Flamen,P,Lerut,A,Van Cutsem,E,Cambier,JP,Maes,A,De,Wever W,Peeters,M,De,Leyn P,Van,Raemdonck D,Mortelmans,L. The utility of positron emission tomography for the diagnosis and staging of recurrent esophageal cancer. J Thorac Cardiovasc Surg 2000;120:1085–1092.

    Article  PubMed  CAS  Google Scholar 

  8. Van Dam,J. Endosonographic evaluation of the patient with esophageal carcinoma. Chest Surg Clin North Am 1994;4:269–284.

    Google Scholar 

  9. Luketich,JD,Schauer,P,Landreneau,R,Nguyen,N,Urso,K,Ferson,P, Keenan,R,Kim,R. Minimally invasive surgical staging is superior to endoscopic ultrasound in detecting lymph node metastases in esophageal cancer. J Thorac Cardiovasc Surg 1997;114:817–823.

    Article  PubMed  CAS  Google Scholar 

  10. Korst,RJ,Rusch,VW,Venkatraman,E,Bains,MS,Burt,ME,Downey,RJ, Ginsberg,RJ. Proposed revision of the staging classification for esophageal cancer. J Thorac Cardiovasc Surg 1998;115:660–670.

    Article  PubMed  CAS  Google Scholar 

  11. Cooper,JS,Guo MD,Herskovic A, Macdonald JS, Martenson, JAJr, Al-Sarraf,M,Byhardt,R,Russell,AH,Beitler,JJ,Spencer,S,Asbell,SO, Graham,MV,Leichman,LL. Chemoradiotherapy of locally advanced esophageal cancer: Long-term followup of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA 1999;281:1623–1627.

    Article  PubMed  CAS  Google Scholar 

  12. Gaspar,LE,Winter,K,Kocha,WI,Coia,LR,Herskovic,A,Graham M. A phase I/II study of external beam radiation, brachytherapy, and concurrent chemotherapy for patients with localized carcinoma of the esophagus (Radiation Therapy Oncology Group Study 9207): Final report. Cancer, 2000;88:988–995.

    Article  PubMed  CAS  Google Scholar 

  13. KingTC,Estalilla,OC,Safran,H. Role of p53 and p16 gene alterations in determining response to concurrent paclitaxel and radiation in solid tumor. Semin Radiat Oncol 1999; 9(Suppl1):4–11.

    Google Scholar 

  14. Mattioli,S,D’Ovidio,F,Tazzari,P,Pilotti,V,Daddi,N,Bandini G,Piccioli,M,Pileri,S. Iliac crest biopsy versus rib segment resection for the detection of bone marrow isolated tumor cells from lung and esophageal cancer. Eur J Cardiothor Surg 2001;19:576–579.

    Article  CAS  Google Scholar 

  15. GehJI,Crellin,AM,Glynne-Jones,R. Preoperative (neoadjuvant) chemoradiotherapy in oesophageal cancer. Br J Surg 2001;88:338–356.

    Article  Google Scholar 

  16. Nygaard,K,Hagen,S,Hansen,HS,Hatlevoll,R,Hultborn,R,Jakobsen,A, Mantyla,M,Modig,H,Munck-Wikland,E,Rosengren,B. Preoperative radiotherapy prolongs survival in operable esophageal carcinoma: A randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second Scandinavian Trial in esophageal cancer. WorldJ Surg 1992; 16:1104–1110.

    Article  CAS  Google Scholar 

  17. Le,Prise E,Etienne,PL,Meunier,B,Maddern,G,Ben,Hassel M,Gedouin,D,Boutin,D,Campion,JP,Launois,B. A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus. Cancer 1994;73:1779–1784.

    Article  Google Scholar 

  18. Apinop,C,Puttisak,P,Preecha,N. A prospective study of combined therapy in esophageal cancer. Hepatogastroenterology 1994;41:391–393.

    PubMed  CAS  Google Scholar 

  19. Walsh,TN,Noonan,N,Hollywood,D,Kelly,A,Keeling,N,Hennessy,TP. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 1996;335:462–467.

    Article  PubMed  CAS  Google Scholar 

  20. BossetJF,GignouxM,Triboulet,JP,Tiret,E,Mantion,G,Elias,D,Lozach,P, Ollier,JC,PavyJJ,Mercier,M,Sahmoud,T. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 1997;337:161–167.

    Article  Google Scholar 

  21. Urba,S. Combined-modality treatment of esophageal cancer. Oncology (Huntingt) 1997; 11(9 Suppl 9):63–67.

    CAS  Google Scholar 

  22. Siewert,JR,Stein,HJ,Fink,U. Multimodality therapy for esophageal cancer. Oncologist 1996;1:210–218.

    PubMed  Google Scholar 

  23. Green,RJ,Haller,DG. Neoadjuvant therapy for cancer of the esophagus. Cancer Control 1999;6:43–52.

    PubMed  Google Scholar 

  24. Swanson,SJ,Batirel,HF,Bueno,R,Jaklitsch,MT,Lukanich,JM,Allred,E, Mentzer,SJ,Sugarbaker,DJ. Transthoracic esophagectomy with radical mediastinal and abdominal lymph node dissection and cervical esophagogastrostomy for esophageal carcinoma. Ann Thorac Surg 2001;72:1918–1924.

    Article  PubMed  CAS  Google Scholar 

  25. Chu,KM,Law,SY,FokM,Wong J. A prospective randomized comparison of transhiatal and transthoracic resection for lowerthird esophageal carcinoma. AmJ Surg 1997;174:320–324.

    Article  CAS  Google Scholar 

  26. Lerut,T,Coosemans,W,De,Leyn P,Deneffe,G,Topal,B,Van de Ven C,Van Raemdonck,D. Reflections on three field lymphadenectomy in carcinoma of the esophagus and gastroesophageal junction. Hepatogastroenterology 1999;46:717–725.

    PubMed  CAS  Google Scholar 

  27. Igaki,H,Kato,H,Tachimori,Y,Sato,H,Daiko,H,Nakanishi,Y. Prognostic evaluation for squamous cell carcinomas of the lower thoracic esophagus treated with three-field lymph node dissection. EuroJ Cardiothorac Surg 2001;19:887–893.

    Article  CAS  Google Scholar 

  28. Dresner,SM,Griffin,SM. Pattern of recurrence following radical oesophagectomy with two-field lymphadenectomy. Br J Surg 2000;87:1426–1433.

    Article  PubMed  CAS  Google Scholar 

  29. Seto,Y,Nagawa,H,Muto,T. Treatment of multiple early gastric cancer. JpnJ Clin Oncol 1996;26:134–138.

    CAS  Google Scholar 

  30. Moreira,LF,Kamikawa,Y,Naomoto,Y,Haisa,M,Orita,K. Endoscopic mucosal resection for superficial carcinoma and high-grade dysplasia of the esophagus. Surg Laparosc Endosc 1995;5:171–175.

    PubMed  CAS  Google Scholar 

  31. Yamamoto,H,Sekine,Y,Higashizawa,T,Kihira,K,Kaneko,Y,Hosoya,Y, Ido,K,Saito,K,Sugano,K. Successful en bloc resection of a large superficial gastric cancer by using sodium hyaluronate and electrocautery incision forceps. Gastrointest Endosc 2001;54:629–632.

    Article  PubMed  CAS  Google Scholar 

  32. Buttar,NS,Wang,KK,Lutzke,LS,Krishnadath,KK,Anderson MA. Combined endoscopic mucosal resection and photodynamic therapy for esophageal neoplasia within Barrett’s esophagus. Gastrointest Endosc 2001;54:682–688.

    PubMed  CAS  Google Scholar 

  33. Etienne,J,Dorme,N,Bourg-Heckly,G,Raimbert,P,Fekete,F. Local curative treatment of superficial adenocarcinoma in Barrett’s esophagus. First results of photodynamic therapy with a new photosensitizer. Bull Acad Natl Med 2000;184:1731–1747.

    PubMed  CAS  Google Scholar 

  34. Gossner,L,Stolte,M,Sroka,R,Rick,K,May,A,Hahn,EG,Ell,C. Photodynamic ablation of high-grade dysplasia and early cancer in Barrett’s esophagus by means of 5-aminolevulinic acid. Gastroenterology 1998;114:448–455.

    Article  PubMed  CAS  Google Scholar 

  35. PanjehpourM,Overholt,BF,HaydekJM,Lee,SG. Results of photodynamic therapy for ablation of dysplasia and early cancer in Barrett’s esophagus and effect of oral steroids on stricture formation. AmJ Gastroenterol 2000;95:2177–2184.

    Article  Google Scholar 

  36. Sibille,A,Lambert,R,Souquet,JC,Sabbeu,G,Descos,F. Long-term survival after photodynamics therapy for esophageal cancer. Gastroenterology 1995;108:337–344.

    Article  PubMed  CAS  Google Scholar 

  37. Narayan,S,Sivak,MV Jr. Palliation of esophageal carcinoma. Laser and photodynamic therapy. Chest Surg Clin North Am 1994;4:347–367.

    CAS  Google Scholar 

  38. Kozarek,RA,Ball,TJ,Brandabur,JJ,Patterson,DJ,Low,D,Hill, L,Raltz,S. Expandable versus conventional esophageal prostheses: Easier insertion may not preclude subsequent stentrelated problems. Gastrointest Endosc 1996;43:204–208.

    Article  PubMed  CAS  Google Scholar 

  39. Dallal,HJ,Smith,GD,Grieve,DC,Ghosh,S,Penman,ID,Palmer,KR. A randomized trial of thermal ablative therapy versus expandable metal stents in the palliative treatment of patients with esophageal carcinoma. Gastrointest Endosc 2001;54:549–557.

    Article  PubMed  CAS  Google Scholar 

  40. Konigsrainer,A,Riedmann,B,De Vries,A,Ofner,D,Spechtenhauser,B,Aigner,F,Fritsch,E,Margreiter,R. Expandable metal stents versus laser combined with radiotherapy for palliation of unresectable esophageal cancer: A prospective randomized trial. Hepatogastroenterology 2000; 47:724–727.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Gastroenterology and Hepatology, Department of Internal Medicine, Mayo Graduate School of Medicine, Rochester, Minnesota

    Kenneth K. Wang M.D.

Authors
  1. Kenneth K. Wang M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kenneth K. Wang M.D..

Additional information

Supported by National Institutes of Health grants CA85992-01 and CA78870-01 and by the Mayo Foundation.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wang, K.K. Multimodality therapy for gastroesophageal cancers. J Gastrointest Surg 6, 527–531 (2002). https://doi.org/10.1016/S1091-255X(02)00027-6

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1016/S1091-255X(02)00027-6

Keywords

Search

Navigation